Referral of Patients With Biological Abnormalities to an Emergency Department (ORA)

Referral of Patients With Biological Abnormalities to an Emergency Department : ORA

Biological testing is an essential part of general medical practice and plays a role in 60% to 70% of diagnoses. 68.5% of prescriptions are written by general practitioners, and one in seven general medical consultations ends with a prescription for biological testing. The study of patient trajectories is a recent emerging topic in the literature, encompassing general concepts. The angle most often taken is medico-economic and focused on specific chronic conditions such as diabetes, cancer, or cardiovascular disease. To our knowledge, there are a number of referrals to emergency departments by general practitioners for patients with biological abnormalities. However, to our knowledge, no study to date has attempted to quantify these specific referrals.

Study Overview

• Status: Not yet recruiting
• Conditions: Emergency Department Visit; General Practitioner; Biological Abnormality

Detailed Description

want to establish a register of biological anomaly referrals by general practitioners to emergency departments. This study will enable us to estimate the number of patients whose referral could have been handled differently, allowing us to develop dedicated care pathways, specialized training in outpatient settings, or targeted communications, ultimately leading to better patient referral and reducing inappropriate use of emergency services.

• Study Type: Observational
• Enrollment (Estimated): 5000

Contacts and Locations

• Study Contact: Name: Andreia CARVALHO DE FREITAS; Phone Number: 0033387553323; Email: projet-recherche-clinique@chr-metz-thionville.fr
• Study Contact Backup: Name: Laure ABENSUR VUILLAUME; Email: laure.abensur-vuillaume@chr-metz-thionville.fr

Study Locations

• France
  • France
    • Metz, France, France, 57085
      • CHR Metz-Thionville

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral "Abnormal laboratory results.

Description

Inclusion Criteria:

• Any patient presenting at an emergency department participating in the IOA (nurse coordinating reception) system with the reason for referral "Abnormal laboratory results.

Exclusion Criteria:

• minor patients (<18 years old)
• expression of the patient's opposition to the collection of data relating to their hospital stay.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Type of biological abnormality and severity level	The primary evaluation criterion is the type of biological abnormality sent to the emergency department and its severity (depth or elevation).	Immediately upon admission to the emergency room

Collaborators and Investigators

• Sponsor: Centre Hospitalier Régional Metz-Thionville

Study record dates

Study Major Dates

• Study Start (Estimated): February 1, 2026
• Primary Completion (Estimated): February 1, 2027
• Study Completion (Estimated): February 1, 2027

Study Registration Dates

• First Submitted: January 27, 2026
• First Submitted That Met QC Criteria: February 9, 2026
• First Posted (Actual): February 12, 2026

Study Record Updates

• Last Update Posted (Actual): February 12, 2026
• Last Update Submitted That Met QC Criteria: February 9, 2026
• Last Verified: January 1, 2026

More Information

Terms related to this study

• Other Study ID Numbers: 2025-06-Obs-CHRMT

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No